---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291290948.md"
description: "Biodexa Pharmaceuticals shares are trading lower after the company announced the pricing of its $3.5 million offering and concurrent private placement of pre-funded warrants and warrants."
datetime: "2026-06-30T12:04:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291290948.md)
  - [en](https://longbridge.com/en/news/291290948.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291290948.md)
generator: "portal-rs"
---

# 

Biodexa Pharmaceuticals shares are trading lower after the company announced the pricing of its $3.5 million offering and concurrent private placement of pre-funded warrants and warrants.

### Related Stocks

- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)

## Related News & Research

- [Biodexa to issue Series M, N and O warrants with $2.85 exercise price pending shareholder approval](https://longbridge.com/en/news/291279347.md)
- [Autonomix Medical Raises $4.9 Million via Warrant Exercise, Issues New Five-Year Warrants](https://longbridge.com/en/news/297088554.md)
- [Karman Line Acquisition says units begin trading separately into shares, warrants Aug. 27](https://longbridge.com/en/news/297045620.md)
- [Inhalation Sciences sets warrant exercise price at SEK 0.12 per share](https://longbridge.com/en/news/296936023.md)
- [Worksport issues new warrants after holder exercises 3,840,421 shares at USD 0.6 each](https://longbridge.com/en/news/297228584.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**